Evidence map›Paper›PMID 29941780›Full record

ArticleMaterials (Basel, Switzerland)2018

The Preservation of Bone Cell Viability in a Human Femoral Head through a Perfusion Bioreactor.

Aparna Swarup, Hilary Weidner, Randall Duncan, Anja Nohe

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aparna SwarupDepartment of Biological Sciences, University of Delaware, 105 The Green, Newark, DE 19716, USA. aswarup@udel.edu.
Hilary WeidnerDepartment of Biological Sciences, University of Delaware, 105 The Green, Newark, DE 19716, USA. weidnerh@udel.edu.
Randall DuncanDepartment of Biological Sciences, University of Delaware, 105 The Green, Newark, DE 19716, USA. rlduncan@udel.edu.
Anja NoheDepartment of Biological Sciences, University of Delaware, 105 The Green, Newark, DE 19716, USA. anjanohe@udel.edu.
University of Delaware · US

Funding

Mechanism of a mimetic peptide CK2.3 on bone formationR01AR064243 · NIAMS · UNIVERSITY OF DELAWARE · PI NOHE, ANJA G · 2013 to 2018
$1.6M
NIAMS NIH HHS R01 AR064243
6 · The paper itself

Abstract

Current methods for drug development and discovery involve pre-clinical analyses that are extremely expensive and time consuming. Animal models are not the best precedent to use, when comparing to human models as they are not synonymous with the human response, thus, alternative methods for drug development are needed. One of which could be the use of an ex vivo human organ where drugs could be tested and the effects of those drugs could be observed. Finding a viable human organ to use in these preliminary ex vivo studies is difficult due to the availability, cost, and viability. Bone tissue and marrow contain a plethora of both bone and stem cells, however, these cells need constant perfusion to be viable over a longer time range. Here we maintain bone cell sustainability in an ex vivo model, through the use of human femoral heads in a novel bioreactor. This bioreactor was designed to directly perfuse cell culture media (DMEM) through the vasculature of a femoral head, providing ideal nutrients and conditions required for maintaining organ viability. We show, for the first time, that cells within a femoral head can stay alive up to 12 h. Further development could be used to determine the effects of drugs on a human organ system and could aid in the understanding of the progression of bone diseases and pathologies.

Indexed as

bioreactorfemoral headperfusion

Identifiers

PMID29941780
PMCPMC6073554
OpenAlexW2808940206

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.